![](https://static.biospace.com/dims4/default/d145e6b/2147483647/strip/true/crop/1254x705+0+65/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fc9%2F37%2Fcf50ad664edcbb38b747efba19be%2Fistock-2148169932.jpg)
With Leqembi Sales Trending Up, Biogen Gets Down to Brass Tacks: It Works
With the launch of Alzheimer’s disease medicine Leqembi charting “slow and steady” growth, Biogen CEO Chris Viehbacher said that promotion can now turn to the actual benefits of the product. “There was an awful lot of effort at the start just to explain …